Print

DTI Medical Corporation Announces Reverse Split and Other Corporate Developments  
9/10/2007 1:02:22 AM

LAS VEGAS, Sept. 7 /PRNewswire-FirstCall/ -- DTI Medical Corporation announced and publicly-noticed its shareholders that it will affect a reverse split of its common stock and authorize its Board of Directors to affect a name change. Questions regarding the reverse split will be handled through the Company's transfer agent, Standard Registrar & Transfer Company, Inc., Draper, Utah. Notice of the intended and pending corporate action is as follows:

NOTICE OF SHAREHOLDER CONSENT IN LIEU OF A SPECIAL MEETING OF THE SHAREHOLDERS OF DTI MEDICAL CORPORATION

The Board of Directors of DTI Medical Corporation, a Nevada corporation ("the Company"), hereby gives notice that pursuant to Nevada Corporate Statutes, a majority of the shareholders of record of the Company, as of September 7, 2007, will consent to the following action effective September 17, 2007.

1. Affect a reverse split of the Company's outstanding common shares for up to a 1 for 300 basis. 2. Authorized the Board of Directors to affect a name change to a name to be selected by the Board.

Proxies of the shareholders are not being solicited by the Board of Directors.

Dated this 7th day of September, 2007. By Order Of: The Board of Directors

Forward-Looking Statements

Statements contained herein that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended. Those statements include statements regarding the intent, belief or current expectations of the company and its management. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, the Company's ability to obtain additional financing and the demand for the Company's products. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events. Factors that may impact the Company's success are more fully disclosed in the Company's most recent public filings with the U.S. Securities and Exchange Commission.

DTI Medical Corporation

CONTACT: Nathan Drage of Nathan W. Drage P.C., +1-801-273-9300, for DTIMedical Corporation


//-->